Research statistics

Atosiban research: publications and trials

What has been published on Atosiban: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Atosiban works or is safe. For what it is and what the studies found, see the Atosiban profile.
Automated weekly refresh · data through November 1, 2026

At a glance

Publications, all years

545

Since 1985

Publications in 2026 so far

17

Through November 1, 2026

Human clinical research

29.4%

158 of 538 classified

Registered clinical trials

22

ClinicalTrials.gov

Randomized controlled trials

56

Publications reporting an RCT in people

Systematic reviews and meta-analyses

29

Preclinical studies

51.3%

206 animal · 66 in vitro · 4 computational

Records that only mention it

106

Not counted above

Status in the library: In clinical trials. 7 publications are not yet classified by study type.

What to keep in mind

  • Some completed trials have neither posted results nor a linked results publication.

Publications by year

Atosiban publications by year and evidence

1985, Preclinical (animal, in vitro, computational): 1 of 11986, Human clinical research: 2 of 31986, Preclinical (animal, in vitro, computational): 1 of 31987, Human clinical research: 1 of 41987, Preclinical (animal, in vitro, computational): 2 of 41987, Other and not yet classified: 1 of 41988, Preclinical (animal, in vitro, computational): 1 of 21988, Other and not yet classified: 1 of 21989, Human clinical research: 1 of 51989, Preclinical (animal, in vitro, computational): 3 of 51989, Other and not yet classified: 1 of 51991, Preclinical (animal, in vitro, computational): 1 of 11992, Preclinical (animal, in vitro, computational): 3 of 41992, Other and not yet classified: 1 of 41993, Human clinical research: 2 of 31993, Preclinical (animal, in vitro, computational): 1 of 31994, Human clinical research: 1 of 71994, Preclinical (animal, in vitro, computational): 6 of 71995, Human clinical research: 3 of 121995, Preclinical (animal, in vitro, computational): 6 of 121995, Reviews and meta-analyses: 2 of 121995, Other and not yet classified: 1 of 121996, Human clinical research: 2 of 71996, Preclinical (animal, in vitro, computational): 5 of 71997, Preclinical (animal, in vitro, computational): 4 of 41998, Preclinical (animal, in vitro, computational): 2 of 51998, Reviews and meta-analyses: 3 of 51999, Preclinical (animal, in vitro, computational): 8 of 91999, Other and not yet classified: 1 of 92000, Human clinical research: 4 of 92000, Preclinical (animal, in vitro, computational): 5 of 92001, Human clinical research: 4 of 162001, Preclinical (animal, in vitro, computational): 8 of 162001, Reviews and meta-analyses: 4 of 162002, Preclinical (animal, in vitro, computational): 4 of 102002, Reviews and meta-analyses: 6 of 102003, Human clinical research: 4 of 182003, Preclinical (animal, in vitro, computational): 9 of 182003, Reviews and meta-analyses: 4 of 182003, Other and not yet classified: 1 of 182004, Human clinical research: 4 of 172004, Preclinical (animal, in vitro, computational): 6 of 172004, Reviews and meta-analyses: 4 of 172004, Other and not yet classified: 3 of 172005, Human clinical research: 3 of 252005, Preclinical (animal, in vitro, computational): 16 of 252005, Reviews and meta-analyses: 3 of 252005, Other and not yet classified: 3 of 252006, Human clinical research: 9 of 182006, Preclinical (animal, in vitro, computational): 4 of 182006, Reviews and meta-analyses: 4 of 182006, Other and not yet classified: 1 of 182007, Human clinical research: 7 of 192007, Preclinical (animal, in vitro, computational): 8 of 192007, Reviews and meta-analyses: 2 of 192007, Other and not yet classified: 2 of 192008, Human clinical research: 7 of 132008, Preclinical (animal, in vitro, computational): 3 of 132008, Reviews and meta-analyses: 2 of 132008, Other and not yet classified: 1 of 132009, Human clinical research: 9 of 222009, Preclinical (animal, in vitro, computational): 7 of 222009, Reviews and meta-analyses: 4 of 222009, Other and not yet classified: 2 of 222010, Human clinical research: 8 of 212010, Preclinical (animal, in vitro, computational): 9 of 212010, Reviews and meta-analyses: 4 of 212011, Human clinical research: 5 of 152011, Preclinical (animal, in vitro, computational): 7 of 152011, Reviews and meta-analyses: 1 of 152011, Other and not yet classified: 2 of 152012, Human clinical research: 6 of 152012, Preclinical (animal, in vitro, computational): 8 of 152012, Reviews and meta-analyses: 1 of 152013, Human clinical research: 6 of 172013, Preclinical (animal, in vitro, computational): 8 of 172013, Reviews and meta-analyses: 3 of 172014, Human clinical research: 5 of 142014, Preclinical (animal, in vitro, computational): 5 of 142014, Reviews and meta-analyses: 3 of 142014, Other and not yet classified: 1 of 142015, Preclinical (animal, in vitro, computational): 7 of 72016, Human clinical research: 7 of 192016, Preclinical (animal, in vitro, computational): 9 of 192016, Reviews and meta-analyses: 3 of 192017, Human clinical research: 4 of 212017, Preclinical (animal, in vitro, computational): 13 of 212017, Reviews and meta-analyses: 3 of 212017, Other and not yet classified: 1 of 212018, Human clinical research: 7 of 242018, Preclinical (animal, in vitro, computational): 13 of 242018, Reviews and meta-analyses: 2 of 242018, Other and not yet classified: 2 of 242019, Human clinical research: 6 of 222019, Preclinical (animal, in vitro, computational): 10 of 222019, Reviews and meta-analyses: 3 of 222019, Other and not yet classified: 3 of 222020, Human clinical research: 6 of 172020, Preclinical (animal, in vitro, computational): 8 of 172020, Reviews and meta-analyses: 2 of 172020, Other and not yet classified: 1 of 172021, Human clinical research: 5 of 192021, Preclinical (animal, in vitro, computational): 11 of 192021, Reviews and meta-analyses: 2 of 192021, Other and not yet classified: 1 of 192022, Human clinical research: 5 of 182022, Preclinical (animal, in vitro, computational): 9 of 182022, Reviews and meta-analyses: 3 of 182022, Other and not yet classified: 1 of 182023, Human clinical research: 7 of 192023, Preclinical (animal, in vitro, computational): 9 of 192023, Reviews and meta-analyses: 2 of 192023, Other and not yet classified: 1 of 192024, Human clinical research: 6 of 162024, Preclinical (animal, in vitro, computational): 10 of 162025, Human clinical research: 8 of 302025, Preclinical (animal, in vitro, computational): 15 of 302025, Reviews and meta-analyses: 2 of 302025, Other and not yet classified: 5 of 302026 (to date), Human clinical research: 4 of 172026 (to date), Preclinical (animal, in vitro, computational): 11 of 172026 (to date), Reviews and meta-analyses: 2 of 17Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified010203019851995200420132026*
Counted PubMed publications by year of first publication. * 2026 runs to November 1, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
198501001
198621003
198712014
198801012
198913015
199101001
199203014
199321003
199416007
1995362112
199625007
199704004
199802305
199908019
200045009
2001484016
2002046010
2003494118
2004464317
20053163325
2006944118
2007782219
2008732113
2009974222
2010894021
2011571215
2012681015
2013683017
2014553114
201507007
2016793019
20174133121
20187132224
20196103322
2020682117
20215112119
2022593118
2023792119
20246100016
20258152530
2026 (to date)4112017

Study types

Animal study206
In vitro study66
Randomized controlled trial56
Observational human study47
Review45
Other clinical trial31
Editorial, letter or other27
Case report24
Meta-analysis18
Systematic review11
Not yet classified7
Computational study4
Correction or retraction notice3

Research areas

From MeSH major topics. A paper can be in several areas.

Reproductive and sexual health332
Neurological and mental health85
Musculoskeletal62
Cardiovascular55
Endocrinology33
Gastrointestinal30
Cognitive health15
Metabolic health14
Immune system13
Oncology11
Antimicrobial and infectious disease7
Tissue repair7

Registered clinical trials

5 of 12 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 12 · Unknown status: 5 · Recruiting: 3 · Terminated: 1 · Withdrawn: 1
Early phase 1: 2 · Phase not applicable: 6 · Phase 1: 2 · Phase 2: 4 · Phase 3: 4 · Phase 4: 4

TrialStatusPhaseStartedResults
Atosiban in Women With Previous Implantation Failure and Abnormal Uterine ContractionsNCT07185230 · 792 enrolledRecruitingPhase not applicable2025-12—
The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )NCT07140237 · 250 enrolledRecruitingEarly phase 12025-09—
The Effect of Oral Oxytocin and Atosiban on Social AttentionNCT07093060 · 250 enrolledRecruitingEarly phase 12025-06—
The Effect of Selective Oxytocin Receptor Inhibitors on Endometriosis-related PainNCT05382143 · 10 enrolledUnknown statusPhase 22022-02—
Effect of Oxytocin Antagonists on Implantation Success Rates of Frozen-thawed Embryo TransferNCT03904745 · 250 enrolledUnknown statusPhase not applicable2020-12—
PoC Study of OBE022 in Threatened Preterm LabourNCT03369262 · 115 enrolledUnknown statusPhase 22018-01—
Perioperative Use of Atosiban for Ultrasound-indicated Cerclage to Reduce Spontaneous Preterm Birth(sPTB)NCT06537778 · 334 enrolledCompletedPhase not applicable2018-01—
Atosiban Versus Placebo in the Treatment of Late Threatened Pre-term BirthNCT05693688 · 760 enrolledCompletedPhase 42017-12—
In Utero Repair of Myelomeningocele: Atosiban Versus TerbutalineNCT04468568 · 25 enrolledCompletedPhase not applicable2017-10—
A Randomized Double Blind Comparison of Atosiban in Patients With RIF Undergoing IVF TreatmentNCT02893722 · 200 enrolledUnknown statusPhase 12017-01—
Tocolytic Therapy for Preterm Labor in Multiple GestationNCT02725736 · 140 enrolledUnknown statusPhase 32016-03—
Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment StudiesNCT02292784 · 98 enrolledCompletedPhase 32015-06Posted
A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm LabourNCT02292771 · 97 enrolledTerminatedPhase 32015-03Posted
Oxidative Stress in Women Treated With Atosiban for Impending Preterm BirthNCT03570294 · 64 enrolledCompletedPhase not applicable2014-02—
Oxytocin Antagonist in Patients With Repeated Failure of ImplantationNCT01673399 · 138 enrolledCompletedPhase 42012-02—
Use of Atosiban in in Vitro Fertilization (IVF) TreatmentNCT01501214 · 800 enrolledCompletedPhase 42011-12—
Nifedipine Treatment in Preterm LaborNCT01314859WithdrawnPhase 32011-07—
Atosiban Improves Implantation and Pregnancy Rates in Patients With Repeated Implantation FailureNCT01493440 · 71 enrolledCompletedPhase not applicable2011-03—
Influence of Tocolytical Medications on Hemodynamics (Central and Peripheral) and Vascular Function in a Pilot Study to Determine the Design of the Final Study and the Final Study ItselfNCT00679705 · 23 enrolledCompletedPhase 12008-05—
Nifedipine Compared to Atosiban for Treating Preterm LaborNCT00599898 · 145 enrolledCompletedPhase 42008-01—
Effect of Oxytocin and Vasopressin Antagonists on Uterine ContractionsNCT00587327 · 125 enrolledCompletedPhase 22007-11—
Single Versus Combination Therapy in Acute TocolysisNCT01429545 · 110 enrolledCompletedPhase 22007-04—

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Atosiban versus nifedipine for the management of preterm labor: a systematic review and meta-analysis of randomized controlled trials.

    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · August 20, 2026 · Meta-analysis · cited 0 times

    PMID 42923929 · DOI 10.61622/rbgo/2026rbgo55 · Reviews and meta-analyses

  2. An individual participant data network meta-analysis of the APOSTEL trials on the effect of tocolysis in threatened preterm birth between 30-33<sup>+6</sup> weeks of gestation in twin pregnancies.

    European journal of obstetrics, gynecology, and reproductive biology · February 3, 2026 · Meta-analysis · cited 0 times · open access

    PMID 41650841 · DOI 10.1016/j.ejogrb.2026.114989 · Reviews and meta-analyses

  3. Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis.

    Frontiers in endocrinology · March 23, 2023 · Meta-analysis · cited 20 times · open access

    PMID 37033236 · DOI 10.3389/fendo.2023.1161707 · Reviews and meta-analyses

  4. Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis.

    BMC pregnancy and childbirth · July 15, 2022 · Meta-analysis · cited 15 times · open access

    PMID 35840927 · DOI 10.1186/s12884-022-04854-1 · Reviews and meta-analyses

  5. Interventions to optimize embryo transfer in women undergoing assisted conception: a comprehensive systematic review and meta-analyses.

    Human reproduction update · June 1, 2022 · Meta-analysis · cited 51 times · open access

    PMID 35325124 · DOI 10.1093/humupd/dmac009 · Reviews and meta-analyses

  6. Is oxytocin receptor antagonist administration around embryo transfer associated with IVF treatment success? A systematic review and meta-analysis.

    Reproductive biomedicine online · August 28, 2021 · Meta-analysis · cited 8 times

    PMID 34686417 · DOI 10.1016/j.rbmo.2021.08.020 · Reviews and meta-analyses

  7. Usefulness of atosiban for tocolysis during external cephalic version: Systematic review and meta-analysis.

    European journal of obstetrics, gynecology, and reproductive biology · December 31, 2020 · Meta-analysis · cited 17 times

    PMID 33421816 · DOI 10.1016/j.ejogrb.2020.12.053 · Reviews and meta-analyses

  8. Atosiban improves the outcome of embryo transfer. A systematic review and meta-analysis of randomized and non-randomized trials.

    JBRA assisted reproduction · October 6, 2020 · Meta-analysis · cited 18 times · open access

    PMID 32401462 · DOI 10.5935/1518-0557.20200016 · Reviews and meta-analyses

  9. Systematic review and meta-analysis of randomized controlled trials of atosiban versus nifedipine for inhibition of preterm labor.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · March 13, 2019 · Meta-analysis · cited 31 times

    PMID 30784056 · DOI 10.1002/ijgo.12793 · Reviews and meta-analyses

  10. Acute tocolysis for uterine tachysystole or suspected fetal distress.

    The Cochrane database of systematic reviews · July 4, 2018 · Meta-analysis · cited 44 times · open access

    PMID 29971813 · DOI 10.1002/14651858.cd009770.pub2 · Reviews and meta-analyses

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery.

    Science (New York, N.Y.) · December 1, 2006 · Animal study · cited 485 times · open access

    PMID 17170309 · DOI 10.1126/science.1133212 · Animal studies

  2. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis.

    BMJ (Clinical research ed.) · October 9, 2012 · Systematic review · cited 419 times · open access

    PMID 23048010 · DOI 10.1136/bmj.e6226 · Reviews and meta-analyses

  3. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.

    American journal of obstetrics and gynecology · May 1, 2000 · Randomized controlled trial · cited 321 times

    PMID 10819855 · DOI 10.1067/mob.2000.95834 · Human clinical research

  4. Oxytocin receptor antagonists for inhibiting preterm labour.

    The Cochrane database of systematic reviews · July 20, 2005 · Meta-analysis · cited 246 times · open access

    PMID 16034931 · DOI 10.1002/14651858.cd004452.pub2 · Reviews and meta-analyses

  5. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study.

    American journal of obstetrics and gynecology · May 1, 2000 · Randomized controlled trial · cited 203 times

    PMID 10819857 · DOI 10.1067/mob.2000.104950 · Human clinical research

Latest publications

  1. Characterization of cisternal, alveolar, and residual milk fractions in dromedary (Camelus dromedarius) and Bactrian camels (Camelus bactrianus).

    Tropical animal health and production · October 10, 2026 · Animal study · cited 0 times

    PMID 42859315 · DOI 10.1007/s11250-026-05386-y · Animal studies

  2. Pharmacological characterization of neuromodulatory systems involved in biased social interaction toward stressed conspecifics in male rats.

    Social neuroscience · October 1, 2026 · Animal study · cited 0 times · open access

    PMID 42820313 · DOI 10.1080/17470919.2026.2742155 · Animal studies

  3. Discovery of an antagonist nanobody targeting the oxytocin receptor with tocolytic effect in mice.

    Nature communications · September 11, 2026 · Animal study · cited 0 times · open access

    PMID 42864336 · DOI 10.1038/s41467-026-77680-0 · Animal studies

  4. Atosiban versus nifedipine for the management of preterm labor: a systematic review and meta-analysis of randomized controlled trials.

    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · August 20, 2026 · Meta-analysis · cited 0 times

    PMID 42923929 · DOI 10.61622/rbgo/2026rbgo55 · Reviews and meta-analyses

  5. Role of the tail of the ventral tegmental area in the regulation of maternal behaviour: a pharmacological study in postpartum rats.

    Neuropharmacology · August 16, 2026 · Animal study · cited 0 times · open access

    PMID 42604662 · DOI 10.1016/j.neuropharm.2026.111147 · Animal studies

  6. Atosiban-Associated Non-cardiogenic Pulmonary Edema in a Dichorionic Diamniotic Twin Pregnancy: A Case Report.

    Cureus · August 3, 2026 · Case report · cited 0 times · open access

    PMID 42688486 · DOI 10.7759/cureus.113838 · Human clinical research

  7. Delicate Balance of Intra- and Inter-Molecular Entropic Effects in S-S Peptide Cyclization.

    The journal of physical chemistry. A · August 1, 2026 · Computational study · cited 0 times

    PMID 42593195 · DOI 10.1021/acs.jpca.6c02548 · Computational studies

  8. Strategies for the Identification of Cyclic Peptide Drugs and Their Impurities.

    Journal of the American Society for Mass Spectrometry · August 1, 2026 · In vitro study · cited 0 times

    PMID 42463469 · DOI 10.1021/jasms.6c00023 · In vitro studies

  9. Structural elucidation of succinimide-derived hydrolytic isomers of atosiban using a conventional CID-based Asp/IsoAsp discrimination strategy.

    RSC advances · July 6, 2026 · In vitro study · cited 0 times · open access

    PMID 42440966 · DOI 10.1039/d6ra03337g · In vitro studies

  10. Inhibitory Effects of Oxytocin on Jejunal Migrating Myoelectric Complex Activity in Fasted Rats: Role of Oxytocin and GLP-1 Receptors.

    Life (Basel, Switzerland) · June 19, 2026 · Animal study · cited 1 times · open access

    PMID 42355554 · DOI 10.3390/life16061029 · Animal studies

Browse all 545 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Antocile; Antocin; Atosiban; Atosibanum; ORF 22164; Tractocile

((TITLE_ABS:"Antocile" OR CHEM:"Antocile") OR (TITLE_ABS:"Antocin" OR CHEM:"Antocin") OR (TITLE_ABS:"Atosiban" OR CHEM:"Atosiban") OR (TITLE_ABS:"Atosibanum" OR CHEM:"Atosibanum") OR (TITLE_ABS:"ORF 22164" OR CHEM:"ORF 22164" OR TITLE_ABS:"ORF22164" OR CHEM:"ORF22164") OR (TITLE_ABS:"Tractocile" OR CHEM:"Tractocile")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 2). Atosiban research statistics (Version weekly-2026-11-01) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/atosiban